Cellosaurus logo
expasy logo

Cellosaurus XP3OS (CVCL_3245)

[Text version]
Cell line name XP3OS
Synonyms Xeroderma Pigmentosum 3 OSaka; GM04314; GM04314B; GM4314
Accession CVCL_3245
Secondary accession CVCL_F511
Resource Identification Initiative To cite this cell line use: XP3OS (RRID:CVCL_3245)
Comments Population: Japanese.
Omics: Deep exome analysis.
Misspelling: XP30S; Note=Occasionally.
Derived from site: In situ; Skin; UBERON=UBERON_0002097.
Cell type: Fibroblast of skin; CL=CL_0002620.
Sequence variations
Disease Xeroderma pigmentosum, complementation group A (NCIt: C3965)
Xeroderma pigmentosum (ORDO: Orphanet_910)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_QW49 (XP3OS iPS)CVCL_3246 (XP3OS(SVT))CVCL_9S65 (XP3R)
Sex of cell Female
Age at sampling 5Y
Category Finite cell line
STR profile Source(s): JCRB=JCRB0303; PubMed=27197874

Markers:
AmelogeninX
CSF1PO10,11
D3S135815,16
D5S81810,11
D7S82011,12
D8S117913,15
D13S3179,11
D16S5399,12
D18S5113
D21S1129,30
FGA22,23
Penta D9
Penta E14,17
TH017
TPOX8,11
vWA14,16

Run an STR similarity search on this cell line
Publications

PubMed=832273
Takebe H., Miki Y., Kozuka T., Furuyama J.-i., Tanaka K., Sasaki M.S., Fujiwara Y., Akiba H.
DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
Cancer Res. 37:490-495(1977)

PubMed=7000335; DOI=10.1016/0304-3835(80)90072-5
Ishizaki K., Yagi T., Takebe H.
Cytotoxic effects of protease inhibitors on human cells. 1. High sensitivity of xeroderma pigmentosum cells to antipain.
Cancer Lett. 10:199-205(1980)

PubMed=2570806; DOI=10.1111/1523-1747.ep12284030
Chang H.-R., Ishizaki K., Sasaki M.S., Toguchida J., Kato M., Nakamura Y., Kawamura S., Moriguchi T., Ikenaga M.
Somatic mosaicism for DNA repair capacity in fibroblasts derived from a group A xeroderma pigmentosum patient.
J. Invest. Dermatol. 93:460-465(1989)

PubMed=1702221; DOI=10.1073/pnas.87.24.9908; PMCID=PMC55283
Satokata I., Tanaka K., Miura N., Miyamoto I., Satoh Y., Kondo S., Okada Y.
Characterization of a splicing mutation in group A xeroderma pigmentosum.
Proc. Natl. Acad. Sci. U.S.A. 87:9908-9912(1990)

CLPUB00447
Mulivor R.A., Suchy S.F.
1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.
(In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992)

PubMed=1372102; DOI=10.1016/0921-8777(92)90080-M
Satokata I., Tanaka K., Miura N., Narita M., Mimaki T., Satoh Y., Kondo S., Okada Y.
Three nonsense mutations responsible for group A xeroderma pigmentosum.
Mutat. Res. 273:193-202(1992)

PubMed=7830260; DOI=10.1269/jrr.35.168
Fujikawa K., Ayaki H., Ishizaki K., Takatera H., Matsuo S., Iizuka H., Koizumi H., Ikenaga M.
Assignment of six patients with xeroderma pigmentosum in Hokkaido area to a variant form.
J. Radiat. Res. 35:168-178(1994)

PubMed=9671271; DOI=10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6
States J.C., McDuffie E.R., Myrand S.P., McDowell M.L., Cleaver J.E.
Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein.
Hum. Mutat. 12:103-113(1998)

PubMed=27197874; DOI=10.1038/srep26342; PMCID=PMC4873825
Okamura K., Sakaguchi H., Sakamoto-Abutani R., Nakanishi M., Nishimura K., Yamazaki-Inoue M., Ohtaka M., Periasamy V.S., Alshatwi A.A., Higuchi A., Hanaoka K., Nakabayashi K., Takada S., Hata K., Toyoda M., Umezawa A.
Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders.
Sci. Rep. 6:26342-26342(2016)

Cross-references
Cell line collections (Providers) Coriell; GM04314
JCRB; JCRB0303
JCRB; KURB1002
JCRB; KURB1003
JCRB; KURB1004
Cell line databases/resources CLO; CLO_0019557
Encyclopedic resources Wikidata; Q54994928
Gene expression databases GEO; GSM1338611
Entry history
Entry creation04-Apr-2012
Last entry update19-Dec-2024
Version number22